The PT and INR are used to monitor the effectiveness of the anticoagulant warfarin. This drug affects the function of the coagulation cascade and helps inhibit the formation of blood clots. It is prescribed on a long-term basis to people who have experienced recurrent inappropriate blood clotting.
IRS Rules on Prototype and Volume Submitter Plans. August 5, 2008. In 2005, sponsors of prototype and volume submitter retirement plan documents were required to update their documents for the Economic Growth Tax Relief and Reconciliation Act of 2001 (âEGTRRAâ) and file these updated documents with the IRS.
Analysis: How CMS handles requests to change the submitter of records was never previously addressed in any of the versions of the WCMSA reference guide. Traditionally, CMS did not allow a change of submitter once a WCMSA decision has been issued, but the new language in the WCMSA reference guide specifies that a change of submitter is not allowed once the claim has settled.